Literature DB >> 28799706

Outcome after transcatheter occlusion of patent ductus arteriosus in infants less than 6 kg: A national study from United Kingdom and Ireland.

Sok-Leng Kang1, Salim Jivanji2, Chetan Mehta3, Andrew J Tometzki1, Graham Derrick2, Robert Yates2, Sachin Khambadkone2, Joseph de Giovanni3, Oliver Stumper3, Rami Dhillon3, Vinay Bhole3, Zdenek Slavik4, Michael Rigby4, Patrick Noonan5, Ben Smith5, Brodie Knight5, Trevor Richens6, Neil Wilson7, Kevin Walsh8, Adam James8, John Thomson9, Jamie Bentham9, Nicholas Hayes6, Sajid Nazir6, Satish Adwani10, Arjamand Shauq11, Ram Ramaraj11, Christopher Duke12, Demetris Taliotis1, Vikram Kudumula12, San-Fui Yong12, Gareth Morgan7, Eric Rosenthal13, Thomas Krasemann13, Shakeel Qureshi13, David Crossland14, Tony Hermuzi14, Robin P Martin1.   

Abstract

OBJECTIVES: This study aimed to report our national experience with transcatheter patent ductus arteriosus (PDA) occlusion in infants weighing <6 kg.
BACKGROUND: The technique of transcatheter PDA closure has evolved in the past two decades and is increasingly used in smaller patients but data on safety and efficacy are limited.
METHODS: Patients weighing < 6 kg in whom transcatheter PDA occlusion was attempted in 13 tertiary paediatric cardiology units in the United Kingdom and Ireland were retrospectively analyzed to review the outcome and complications.
RESULTS: A total of 408 patients underwent attempted transcatheter PDA closure between January 2004 and December 2014. The mean weight at catheterization was 4.9 ± 1.0 kg and mean age was 5.7 ± 3.0 months. Successful device implantation was achieved in 374 (92%) patients without major complication and of these, complete occlusion was achieved in 356 (95%) patients at last available follow-up. Device embolization occurred in 20 cases (5%). The incidence of device related obstruction to the left pulmonary artery or aorta and access related peripheral vascular injury were low. There were no deaths related to the procedure.
CONCLUSIONS: Transcatheter closure of PDA can be accomplished in selected infants weighing <6 kg despite the manufacturer's recommended weight limit of 6 kg for most ductal occluders. The embolization rate is higher than previously reported in larger patients. Retrievability of the occluder and duct morphology needs careful consideration before deciding whether surgical ligation or transcatheter therapy is the better treatment option.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Paediatrics; cardiac catheterization; congenital; heart defects

Mesh:

Year:  2017        PMID: 28799706     DOI: 10.1002/ccd.27212

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  Ductal closure in infants under 6 kg including premature infants using AmplatzerTM duct occluder type two additional sizes: a single-centre experience in South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Makrexeni; Samkelo Jiyana
Journal:  Cardiovasc J Afr       Date:  2019-08-30       Impact factor: 1.167

2.  Transcatheter closure through single venous approach for young children with patent ductus arteriosus: A retrospective study of 686 cases.

Authors:  Jun Liu; Lei Gao; Hui-Lian Tan; Qing-Hou Zheng; Ling Liu; Zhen Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

3.  Trends in surgical and catheter interventions for isolated congenital shunt lesions in the UK and Ireland.

Authors:  Mehreen Farooqi; John Stickley; Rami Dhillon; David J Barron; Oliver Stumper; Timothy J Jones; Paul F Clift; William J Brawn; Nigel E Drury
Journal:  Heart       Date:  2019-02-16       Impact factor: 5.994

Review 4.  Recent advances in cardiac catheterization for congenital heart disease.

Authors:  Sok-Leng Kang; Lee Benson
Journal:  F1000Res       Date:  2018-03-26

5.  Case 6 / 2018 - Percutaneous Occlusion of a Large Ductus Arteriosus in a Low Weight Infant, with Immediate Clinical and Radiographic Improvement.

Authors:  Pablo Tomé Teixeirense; Vanessa de Moraes Sousa; João Felipe Barros de Toledo; Luiz Antonio Gubolino
Journal:  Arq Bras Cardiol       Date:  2018-11       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.